Momegalen (Mometasone Furoate Ph. Eur.)

Mometasone furoate, the active ingredient in Momegalen, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation associated with allergic rhinitis and nasal polyps, providing symptom relief for patients requiring prescription therapy. It is indicated for individuals who experience persistent nasal congestion, sneezing and itching due to seasonal or perennial allergens.

GNH USA supplies Momegalen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Momegalen (mometasone furoate) is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, sneezing and itching. - Nasal polyps: decreases polyp size and improves airflow. - Seasonal allergic rhinitis: provides symptom control during pollen seasons.

Momegalen may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation. - Cough. - Altered taste perception.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes such as cataracts or glaucoma. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal cavity.

Before using Momegalen, consider the following precautions. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: unknown safety; weigh potential benefits against risks. - Use in children: follow pediatric dosing recommendations. - Concomitant nasal decongestants: avoid simultaneous use to reduce irritation risk. - Prolonged high‑dose therapy: monitor for signs of adrenal suppression. - Store at room temperature: keep in the original container, protect from moisture and heat.

Momegalen may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live nasal vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance overall allergy control. - Nasal saline irrigation: could affect drug deposition. - Immunosuppressants: monitor for additive immunosuppression.